J. Berbaum

Biphenyl/diphenyl ether renin inhibitors: filling the S1 pocket of renin via the S3 pocket.

R. Bentley, C. Doe, Suresh B. Singh, 2011, Bioorganic & medicinal chemistry letters.

Structure-based design and synthesis of 1,3-oxazinan-2-one inhibitors of 11β-hydroxysteroid dehydrogenase type 1.

Suresh B. Singh, P. Carroll, D. Claremon, 2011, Journal of medicinal chemistry.

Comparison of full-length versus ligand binding domain constructs in cell-free and cell-based peroxisome proliferator-activated receptor alpha assays.

J. Berbaum, R. Harrison, 2005, Analytical biochemistry.

JD-5006 and JD-5037: peripherally restricted (PR) cannabinoid-1 receptor blockers related to SLV-319 (Ibipinabant) as metabolic disorder therapeutics devoid of CNS liabilities.

Jennifer Berbaum, J. Berbaum, Robert J Chorvat, 2012, Bioorganic & medicinal chemistry letters.

Discovery and optimization of adamantyl carbamate inhibitors of 11β-HSD1.

R. Gregg, Suresh B. Singh, H. Nar, 2010, Bioorganic & medicinal chemistry letters.

Spirocyclic ureas: orally bioavailable 11 beta-HSD1 inhibitors identified by computer-aided drug design.

Suresh B. Singh, D. Claremon, C. Tice, 2010, Bioorganic & medicinal chemistry letters.

Generation and validation of rapid computational filters for cyp2d6 and cyp3a4.

Sean Ekins, S. Ekins, Jennifer Berbaum, 2003, Drug metabolism and disposition: the biological fate of chemicals.